Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can a video game tame emotional outbursts in kids?

NCT ID NCT04732806

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested whether a biofeedback video game called Mightier can help children aged 8-12 with emotional dysregulation. 183 kids were randomly assigned to play the game at home or receive usual care for 6 months. Researchers tracked symptoms, parent stress, and healthcare costs over a year to see if the game reduces aggression and the need for expensive mental health services.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mightier video game (biofeedback game)
What this could lead to
If it works, this could offer a fun, accessible way for children to learn emotional control and reduce the need for costly mental health services.
What could go wrong
This is a completed pilot study with 183 participants, not a large-scale trial. The game may not work for all children, and results depend on consistent home use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

183 people

The number who actually took part.

Started

Mar 2021

Finished

Oct 2025

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 12 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion: * Age 8-12 * Insurance provided by Magellan Healthcare OR participant is covered by insurance in Massachusetts and has access to Explanation of Benefits information via online portal * Has made a behavioral health claim in the past year * MOAS score of greater than or equal to 2 * Evidence of ADHD, ODD, CD, DMDD, IED, or ASD by MINI-KID * Parent or guardian is fluent in English * WiFi at home (for Mightier tablet connection) * Access to a computer or tablet in the home Exclusion: * IQ \< 70 (by medical record or clinician judgment) * Extremely limited verbal capacity * Change in medication or medication dosage in the past month or planned change in medication or medication dosage in the next month * Active suicidal ideation * History of suicide attempt and current depression * Physical limitations that preclude the use of Mightier * Sensory sensitivities that would preclude wearing an arm (or leg) heart rate monitor * Evidence of psychosis, mania, alcohol use disorder, substance use disorder, or PTSD by MINI-Kid * Ongoing or within the month prior to baseline visit placement in foster care or residential facility

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Attention deficit hyperactivity disorder are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Neuromotion Inc

    Boston, Massachusetts, 02110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.